Citadel Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.7K Buy
+12,454
New +$47.7K ﹤0.01% 5472
2025
Q1
Sell
-85,642
Closed -$427K 5896
2024
Q4
$427K Buy
85,642
+31,491
+58% +$157K ﹤0.01% 4164
2024
Q3
$292K Buy
54,151
+44,587
+466% +$240K ﹤0.01% 4316
2024
Q2
$31.7K Sell
9,564
-45,684
-83% -$151K ﹤0.01% 5295
2024
Q1
$181K Sell
55,248
-12,481
-18% -$40.8K ﹤0.01% 4838
2023
Q4
$238K Sell
67,729
-222,070
-77% -$779K ﹤0.01% 4440
2023
Q3
$1.94M Buy
289,799
+134,651
+87% +$899K ﹤0.01% 2423
2023
Q2
$1.3M Sell
155,148
-33,095
-18% -$278K ﹤0.01% 2757
2023
Q1
$1.87M Sell
188,243
-521,910
-73% -$5.18M ﹤0.01% 2603
2022
Q4
$4.94M Sell
710,153
-953,975
-57% -$6.64M ﹤0.01% 1807
2022
Q3
$8.89M Sell
1,664,128
-654,050
-28% -$3.49M ﹤0.01% 1371
2022
Q2
$9.25M Sell
2,318,178
-161,358
-7% -$644K ﹤0.01% 1337
2022
Q1
$11M Buy
2,479,536
+2,190,919
+759% +$9.74M ﹤0.01% 1329
2021
Q4
$1.15M Buy
288,617
+240,484
+500% +$962K ﹤0.01% 3646
2021
Q3
$423K Buy
48,133
+20,056
+71% +$176K ﹤0.01% 4702
2021
Q2
$318K Sell
28,077
-229,315
-89% -$2.6M ﹤0.01% 5144
2021
Q1
$3.06M Sell
257,392
-1,068,295
-81% -$12.7M ﹤0.01% 2706
2020
Q4
$9.09M Buy
1,325,687
+296,868
+29% +$2.04M ﹤0.01% 1324
2020
Q3
$7.62M Buy
1,028,819
+975,512
+1,830% +$7.23M ﹤0.01% 1264
2020
Q2
$223K Buy
53,307
+15,101
+40% +$63.2K ﹤0.01% 4006
2020
Q1
$95K Buy
38,206
+8,843
+30% +$22K ﹤0.01% 4373
2019
Q4
$171K Buy
29,363
+12,148
+71% +$70.7K ﹤0.01% 4172
2019
Q3
$91K Buy
17,215
+5,810
+51% +$30.7K ﹤0.01% 4275
2019
Q2
$68K Sell
11,405
-21,503
-65% -$128K ﹤0.01% 4313
2019
Q1
$297K Buy
32,908
+19,960
+154% +$180K ﹤0.01% 3737
2018
Q4
$107K Buy
+12,948
New +$107K ﹤0.01% 3997
2018
Q3
Sell
-11,409
Closed -$91K 4242
2018
Q2
$91K Buy
11,409
+159
+1% +$1.27K ﹤0.01% 3846
2018
Q1
$84K Buy
+11,250
New +$84K ﹤0.01% 3659